ARTICLE | Politics, Policy & Law
U.K., ABPI agree to new voluntary pricing scheme
Five-year deal allows increased spending growth, incentivizes uptake of new medicines
November 21, 2023 5:59 PM UTC
The U.K. government and biopharma industry have reached an agreement on a new medicines pricing scheme that will reverse the recent increases in rebates industry pays, and allow more growth in sales of medicines.
On Monday, the U.K. government and the Association of the British Pharmaceutical Industry (ABPI) announced an agreement on the latest five-year voluntary scheme for pricing of branded medicines pricing, access and growth (VPAG) that covers the sales of branded medicines in the U.K. through December 2028. ...